They compare patients initiating treatment in a given month to those who initiate 12 months later in a one-year follow-up design and 60 months later in a five-year follow-up design, allowing them to control for underlying time trends and baseline health differences
Other reported effects include water retention, joint stiffness, carpal-tunnel-type symptoms, raised blood glucose, and injection-site reactions
Conclusion : Retatrutide offers a multifaceted approach to managing the comorbidities of obesity
1 2 Analysts have projected that the longer TRIUMPH-1 trial (80 weeks) could show weight loss exceeding 30%
Until then, the Phase 2 data are unambiguous: adding the glucagon receptor to the GLP-1/GIP framework appears to yield greater fat loss meaningfully, at the cost of a somewhat higher side-effect burden
Personal Opinion: I think injection day selection matters more than people realize